Loading clinical trials...
Loading clinical trials...
Individuals with kidney failure receiving maintenance hemodialysis (HD) have high mortality rates, driven largely by cardiovascular causes. Volume-related factors are critical, modifiable contributors to cardiovascular complications. Reversing volume overload has been shown to improve blood pressure and cardiac remodeling. Use of loop diuretics may represent a pragmatic, low-cost, and low-burden strategy to improve outcomes in people receiving HD. Lack of data on optimal furosemide dosing, safety, and acceptability are barriers to expanded use. This study investigates whether oral furosemide is safe and effective at increasing urine volume in HD patients.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Carolina Dialysis - Carrboro
Carrboro, North Carolina, United States
Carolina Dialysis - Pittsboro
Pittsboro, North Carolina, United States
Carolina Dialysis - Sanford
Sanford, North Carolina, United States
Carolina Dialysis - Lee County
Sanford, North Carolina, United States
Carolina Dialysis - Siler City
Siler City, North Carolina, United States
Start Date
October 7, 2020
Primary Completion Date
June 8, 2021
Completion Date
June 22, 2021
Last Updated
June 13, 2022
39
ACTUAL participants
Furosemide (loop diuretic) Tablets
DRUG
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03535922